Lv32
280 积分 2024-11-13 加入
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
1小时前
待确认
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
1小时前
已完结
The Joint Task Force on Practice Parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis
15小时前
已完结
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
15天前
已完结
Stapokibart for Severe Uncontrolled Chronic Rhinosinusitis With Nasal Polyps The CROWNS-2 Randomized Clinical Trial
17天前
已完结
Remission in chronic rhinosinusitis with nasal polyps treated with biologics: a real-life experience
17天前
已完结
Budenoside aqueous nasal spray: an updated review in managing chronic rhinosinusitis with nasal polyps
1个月前
已完结
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
1个月前
已完结
Stapokibart for Severe Uncontrolled Chronic Rhinosinusitis With Nasal Polyps
1个月前
已完结
Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study
1个月前
已完结
皖公网安备34019202002308
